Spero Therapeutics, Inc. (SPRO)
1.21
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 11:25
Spero Therapeutics EPS Diluted (TTM) : 0.1091 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1091 |
| March 31, 2026 | 0.2436 |
| December 31, 2025 | 0.119 |
| September 30, 2025 | -0.7949 |
| June 30, 2025 | -0.9805 |
| March 31, 2025 | -1.281 |
| December 31, 2024 | -1.268 |
| September 30, 2024 | 0.0794 |
| June 30, 2024 | 0.3354 |
| March 31, 2024 | 0.4398 |
| December 31, 2023 | 0.4239 |
| September 30, 2023 | 0.0095 |
| June 30, 2023 | -0.2551 |
| March 31, 2023 | -0.8982 |
| December 31, 2022 | -1.652 |
| September 30, 2022 | -3.107 |
| June 30, 2022 | -3.482 |
| March 31, 2022 | -3.238 |
| Date | Value |
|---|---|
| December 31, 2021 | -2.892 |
| September 30, 2021 | -2.666 |
| June 30, 2021 | -2.828 |
| March 31, 2021 | -3.051 |
| December 31, 2020 | -3.608 |
| September 30, 2020 | -4.240 |
| June 30, 2020 | -4.326 |
| March 31, 2020 | -4.222 |
| December 31, 2019 | -3.300 |
| September 30, 2019 | -2.586 |
| June 30, 2019 | -2.235 |
| March 31, 2019 | -2.184 |
| December 31, 2018 | -2.630 |
| September 30, 2018 | -3.622 |
| June 30, 2018 | -39.04 |
| March 31, 2018 | -38.35 |
| December 31, 2017 | -37.61 |
| September 30, 2017 | -36.02 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -1.176 |
| Fortress Biotech, Inc. | 2.657 |
| Kura Oncology, Inc. | -3.362 |
| Legend Biotech Corp. | -0.5051 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |